Wednesday, October 1, 2025

Here's How I Roughly Doubled the Market's Performance Last Quarter

By 2011, I was furious with the investment-management business... The S&P 500 Index and Nasdaq Composite Index ripped higher in the late 1990s. Many folks got comfortable with anything and everything going up.

This Post-FOMC Sector is Already Paying Out (20% Winner)

Trade of the Day Wake-Up Watchlist

"Pfizer's latest plan to lower drug costs has it on my radar for a trade this week."

Karim Rahemtulla, Head Fundamental Tactician, Monument Traders Alliance

Karim Rahemtulla

Ever since the FOMC cut interest rates in September, we've been watching the healthcare sector for trades in The War Room.

We've already cashed one winner this week.

Yesterday, my colleague Bryan Bottarelli closed a 20% gain on pharma group Eli Lilly and Company (LLY) in less than 30 minutes.

The move came after President Trump announced a 100% tariff on branded drugs imported into the U.S., benefitting companies like LLY.

 

 

Here's what a few War Room members had to say about the LLY trade…

 

While this is a strong start for healthcare stocks post-FOMC, I believe it's just the beginning.

I'm currently tracking a long-term trade opportunity on a company that could benefit from a major government health initiative.

Here's the breakdown…

Yesterday, the White House announced a plan for a direct-to-consumer website for Americans to buy drugs, dubbed TrumpRx.

TrumpRx would allow people to pay cash for certain drugs directly from a government website, at a discounted price negotiated by the government.

But that's not all.

It also announced that pharma group Pfizer (PFE) is planning to lower prices on several of its medications in the U.S.

It's unclear how many drugs would be offered.

But overall, Pfizer is expected to be the first to announce a plan to lower drug costs after President Trump pushed companies for months to lower prices in the U.S.

Albert Bourla, the chief executive of Pfizer, announced the cost-cutting measure at the White House yesterday.

He also announced a $70 billion investment on manufacturing medications in the United States.

This news could be big for PFE.

It's why it's one of my top watchlist stocks for a potential long-term play this week.

 

SPONSORED

You WILL buy these four miners [now or when the herd panics]

BREAKING: Trump’s “Big Beautiful Bill” Passed – which guarantees the US will add another $10 trillion to its already massive debt pile. This means big beautiful gains are coming to the best gold miners – because gold runs higher and longer in times of out of control monetary inflation.

Go here to learn about the four “Golden Anomaly” miners selling at discounts up to 90% below the value of their gold in the ground

Action Plan: With Pfizer's latest announcement to lower drug prices and Trump's new TrumpRx initiative, I believe it's a long-term trade candidate right now.

To see exactly how I'm playing this news, I invite you to join Bryan and I in The War Room. Last month, we closed 79% of our trades for winners. And after the Fed's latest interest rate cuts, I believe we could see more buy opportunities over the next 90 days.

Click here to join The War Room today.

SPONSORED

See Spike... Target 293%!

WAR Volume
 

It's almost too easy...

  1. See THIS spike the day BEFORE earnings
  2. Make ONE trade by 4 pm...
  3. Get out the next morning!

It's led to REAL top gains of 124%... 293%... 190%...

Discover The Pre-Earnings Spike

5 Spots Reopened (Payment Failures)


Cards declined overnight — act fast
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

10/01/2025

First off… welcome to Q4! I hope the rest of 2025 treats you well.


Now, yesterday, I told you there was just 1 final seat in Overnight Trader.


That was true and you never accepted...


But overnight, previous spots that were attempted to be taken, weren't cleared due to transaction failures. Credit cards declined, payments failed, or some other hiccup.


That means 5 spots are back on the table.


If you thought you missed your chance, this is your second shot.


Here's the thing: while Wall Street analysts argue endlessly about interest rates and inflation, they're really just guessing.


Meanwhile, the biggest gains aren't coming from forecasts… they're coming from the whiplash moves happening every single day.


And that's exactly where Overnight Trader thrives.


This isn't about long-term predictions or complicated economic models. It's about taking advantage of short-term price swings with speed and precision.


Because when markets lurch higher or lower, opportunities open up fast — and you need a system that knows how to spot them.


That's where we come in. Overnight Trader is built to turn volatility into profit potential, with trade alerts that spell out the exact entry and exit points, include risk protection already factored in, and operate on a timeline measured in hours or days, not months.


While the so-called "experts" keep telling the public to sit tight and be patient… we've been cashing in on setups like:

  • 359.5% on Apple puts (in and out in 24 hours)

  • 62.2% on Affirm Holdings calls

  • 79.7% on Snowflake puts

  • 58.9% on Kroger calls

  • 58.2% on Workday puts

Those numbers aren't hype. They're real trades, delivered in real time, using a strategy built specifically for volatile markets like this one.


And here's what you won't hear on TV: Volatility isn't a problem. It's the opportunity.


Sharp price swings create inefficiencies, overreactions, and mispriced options.


When you know how to spot them (the way we do) you don't need to "wait it out."


You just need a process that consistently identifies them and acts.


That's exactly what Overnight Trader provides: high-conviction trade alerts (up to 4 per month) with defined entry and exit levels and risk management already built in.


Most trades finish in hours, not weeks or months.


And right now, you can secure Lifetime Access for $79 (normally $1,747 per year).


I'm extending this until the final spots are filled. But I can't promise that more failed payments or card declines will keep seats open.


This is your chance to trade smarter, faster, and with more confidence.


You in?

Join Right Now!

Sincerely,


Bernie Schaeffer

Founder & CEO

Schaeffer's Investment Research

service@sir-inc.com

1-800-448-2080

http://www.schaeffersresearch.com


Thank you for being a valued member of the Schaeffer's community. We look forward to helping you achieve your investment goals.

>> Today's Bernie Bonus: Top 3 Buy-Rated Stocks Under $10 πŸ“ˆ


To ensure delivery of this email to your inbox and to enable images to load in future mailings, please add enews@schaeffer.com & editor@m.schaeffersresearch.com to your e-mail address book or safe senders list.


Although there is significant profit potential associated with buying options, there is also the risk of losing one's entire investment in any individual trade. In any option buying approach, it is expected that losing trades will be more numerous than winning trades. The goal is for the average gain to be significantly greater than the average loss so that the bottom line is profitable. Prior to purchase, ensure that you have a broker that allows the trading of options and that you are approved to trade options.



Page List

Blog Archive

Search This Blog

Access our “Green Day” system here

...